ACM
CC icon

Armbruster Capital Management’s Chemours CC Stock Holding History

Armbruster Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20
Closed – – 291
2016
Q1 		$0 Hold
20
– – ﹤0.01% 299
2015
Q4 		$0 Buy
+20
New +$128 ﹤0.01% 300

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Armbruster Capital Management's CC Position: Q2 2016 in Review

Armbruster Capital Management sold out of Chemours (CC) in Q2 2016, closing a stake of 20 shares.

Armbruster Capital Management first reported a position in CC in Q4 2015 and held it in 2 quarters. The position peaked at $0 in Q1 2016. 371 funds tracked by Wall St. Rank hold CC as of Q2 2016.

  • Armbruster Capital Management reported no remaining Chemours position as of Q2 2016 after selling out during the quarter.
  • Armbruster Capital Management sold 20 Chemours shares in Q2 2016.
  • Armbruster Capital Management first reported a position in Chemours in Q4 2015 and held it in 2 quarters.
  • Armbruster Capital Management's Chemours position peaked at $0 in Q1 2016.
  • 371 funds tracked by Wall St. Rank held Chemours as of Q2 2016.

Based on Armbruster Capital Management's 13F filing for Q2 2016, filed 29 Jul 2016.